All Stories

  1. Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis
  2. Book Comment: The Pharmacist Guide to Implementing Pharmaceutical Care
  3. Methodological quality assessment of network meta-analysis of drug interventions: implications from a systematic review
  4. Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis
  5. Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
  6. A model for the financial assessment of professional services in community pharmacy: A systematic review
  7. Medical Treatments for Acromegaly: A Systematic Review and Network Meta-Analysis
  8. Differences and similarities between Journal Impact Factor and CiteScore
  9. An innovative and comprehensive technique to evaluate different measures of medication adherence: The network meta-analysis
  10. Mapping the characteristics of network meta-analyses on drug therapy: A systematic review
  11. Impact of discharge medication counseling in the cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial
  12. Pharmacist-led discharge medication counselling: A scoping review
  13. A case study of polypharmacy management in nine European countries: Implications for change management and implementation
  14. Cross-cultural adaptation and validation of a European Portuguese version of the 8-item Morisky medication adherence scale
  15. Scholarly publishing depends on peer reviewers
  16. Letter to the Editor Re: “Limited Health Literacy in Portugal Assessed with the Newest Vital Sign” by Dagmara Paiva and Colleagues. Acta Med Port. 2017;30(12):861-869.
  17. Response to the letter entitled: Developing an adherence in hypertension questionnaire short version, MUAH-16: Statistical and methodological issues
  18. Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials
  19. Cross-cultural adaptation of Hypertension Knowledge Test into European Portuguese
  20. Characterization of pharmacists' interventions in asthma management: A systematic review
  21. Impact on process results of clinical decision support systems (CDSSs) applied to medication use: overview of systematic reviews
  22. Algoritmo de tratamento guiado pelo fator XIII reduz a transfusão sanguínea na cirurgia de queimados
  23. Developing an adherence in hypertension questionnaire short version: MUAH-16
  24. A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people
  25. Development of a tool to assess the completeness of drug information sources for health care professionals: A Delphi study
  26. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners
  27. Redefining the pharmacology and pharmacy subject category in the journal citation reports using medical subject headings (MeSH)
  28. Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis
  29. New pharmacy-specific Medical Subject Headings included in the 2017 database
  30. Influence of the mode of administration on the results of medication adherence questionnaires
  31. Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review
  32. Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
  33. The complexity of implementation factors in professional pharmacy services
  34. Diethylpropion and mazindol: An end to the discussion?
  35. Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
  36. Analysis of ten years of publishing in Pharmacy Practice
  37. Polypharmacy management programmes: the SIMPATHY Project
  38. Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy
  39. Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
  40. Current perceptions of the term Clinical Pharmacy and its relationship to Pharmaceutical Care: a survey of members of the European Society of Clinical Pharmacy
  41. Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24
  42. Bradford’s law, the long tail principle, and transparency in Journal Impact Factor calculations
  43. A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease
  44. A Comparison of Patient-Centered Care in Pharmacy Curricula in the United States and Europe
  45. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics
  46. Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions
  47. Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective
  48. Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach
  49. Characterization of published randomized controlled trials assessing clinical pharmacy services around the world
  50. Quality of drug information for healthcare professionals: The ARCA acronym
  51. Pharmacists' interventions on clinical asthma outcomes: a systematic review
  52. Adverse events and treatment failure leading to discontinuation of recently approved antipsychotic drugs in schizophrenia: A network meta-analysis
  53. Differences in the information about procedures after cold chain disruption provided by pharmaceutical industry to hospital and community pharmacies
  54. Quality of pharmacy-specific Medical Subject Headings (MeSH) assignment in pharmacy journals indexed in MEDLINE
  55. Cesación tabáquica en farmacia comunitaria: resultados preliminares de un programa de atención farmacéutica
  56. Lack of harmonisation in the classification of renal impairment in European Summaries of Product Characteristics
  57. Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000–2010)
  58. A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework
  59. Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation
  60. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT
  61. Departamentos de práctica farmacéutica en el mundo, en 2006
  62. Critical assessment of the systematic review on hospitalization resulting from medicine related problems
  63. Characterization of the Medical Subject Headings thesaurus for pharmacy
  64. Assessment of the peer-reviewers’ selection process in the journal Pharmacy Practice
  65. Identification of Pharmacy-specific Medical Subject Headings (MeSH) Lacking in the MeSH Thesaurus
  66. Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals
  67. Open access, predatory publishing and peer-review
  68. Think Tank: Relatório Estratégico sobre Publicação Científica Biomédica em Portugal
  69. Prácticas de prescripción de nutrición parenteral neonatal en Portugal
  70. Renal nurses' views of the potential role of pharmacists in outpatient dialysis centres: a qualitative study
  71. Assessing the impact of multi-compartment compliance aids on clinical outcomes in the elderly: a pilot study
  72. Impact of a program to reduce the dispensing of antibiotics without a prescription in Spain
  73. Defining professional pharmacy services in community pharmacy
  74. Newest Vital Sign as a proxy for medication adherence in older adults
  75. Assessing the Implementability of Clinical Pharmacist Interventions in Patients With Chronic Kidney Disease: An Analysis of Systematic Reviews
  76. Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment
  77. A Tool to Characterize the Components of Pharmacist Interventions in Clinical Pharmacy Services: The DEPICT Project
  78. Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients
  79. Cross-cultural adaptation of the Beliefs about Medicines Questionnaire into Portuguese
  80. Worldwide analysis of factors associated with medicines compendia publishing
  81. What is ‘pharmaceutical care’ in 2013?
  82. Exploring the role of pharmacists in outpatient dialysis centers: a qualitative study of nephrologist views
  83. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study
  84. A Computer-Assisted Prescription System to Improve Antibacterial Surgical Prophylaxis
  85. Pharmacy Practice suffered a plagiarism case
  86. e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers
  87. Evaluation of the Pharmacy Safety Climate Questionnaire in European community pharmacies
  88. Designing a model to minimize inequities in hemodialysis facilities distribution
  89. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review
  90. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil
  91. Quality of surgical antibiotic prophylaxis using E-prescrption conditioning
  92. Avaliação econômica do seguimento farmacoterapêutico em pacientes com diabetes melito tipo 2 em farmácias comunitárias
  93. Tradução para o português e validação do instrumento Diabetes Quality of Life Measure (DQOL-Brasil)
  94. Perfil dos farmacêuticos e farmácias em Santa Catarina: indicadores de estrutura e processo
  95. Validação do mini-questionário de qualidade de vida em hipertensão arterial (MINICHAL) para o português (Brasil)
  96. Tradução e validação para o português do Medication Regimen Complexity Index
  97. Barreras para la implantación de servicios cognitivos en la farmacia comunitaria española
  98. Clinical Pharmacology Information in Summaries of Product Characteristics and Package Inserts
  99. Acceso de los profesionales a los prospectos de los medicamentos
  100. Antidepressant utilization in primary care in a Spanish region
  101. Humanistic outcomes in hypertension research and practice
  102. Medicine-related problems resulting in emergency department visits
  103. Terminology for problems related to drug use
  104. Providing Patient Care in Community Pharmacies in Spain
  105. From "drug-related problems" to "negative clinical outcomes"
  106. Indicaciones autorizadas en España de los fármacos antiosteoporóticos
  107. Pharmaceutical Care in Community Pharmacies: Practice and Research from Around the World
  108. Respuesta de la industria farmacéutica ante una consulta específica
  109. Morbidity and Mortality Associated with Pharmacotherapy. Evolution and Current Concept of Drug-Related Problems
  110. Continuing education and community pharmacists in Galicia: a study of opinions
  111. Importance of medicine-related problems as risk factors
  112. Product Monographs Supplied by Drug Manufacturers to Community Pharmacists in Spain